FDA Inspection 673156 — R-Pharm Germany GmbH

R-Pharm Germany GmbH — FEI 3002807165

The FDA completed an inspection of R-Pharm Germany GmbH on June 18, 2010 in Illertissen. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 18, 2010
Fiscal Year
2010
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Illertissen (Germany)